1. Fraudulent and Substandard Medicines

   • I. Ralph Edwards

   Editorial 20 November 2012 Pages: 445 - 448

2. A Benefit-Risk Assessment of Dabigatran in the Prevention of Venous Thromboembolism in Orthopaedic Surgery

   • Sam Schulman
   • Ammar Majeed

   Review Article 20 November 2012 Pages: 449 - 463

   

3. Quinolones

   • Ana Maria Tomé
   • Augusto Filipe

   Review Article 20 November 2012 Pages: 465 - 488

   

4. Impact of a Pharmacotherapeutic Programme on Control and Safety of Long-Term Anticoagulation Treatment

   • Carmen Duran-Parrondo
   • Juan M. Vazquez-Lago
   • Adolfo Figueiras

   Original Research Article 20 November 2012 Pages: 489 - 500

   

5. Risk of Depressive Episodes with Rimonabant

   • Yvonne Buggy
   • Victoria Cornelius
   • Saad A.W. Shakir

   Original Research Article 20 November 2012 Pages: 501 - 509

   

6. Prescription Patterns in Asthma Patients Initiating Salmeterol in UK General Practice

   • Rachael L. Di Santostefano
   • Kourtney J. Davis

   Original Research Article 20 November 2012 Pages: 511 - 520

   

7. Fatal Toxicity from Symptomatic Hyperlactataemia

   • Liza Leung
   • Douglas Wilson
   • Alex F. Manini

   Original Research Article 20 November 2012 Pages: 521 - 527

   

8. The New EU Legislation on Pharmacovigilance and Changing Models for Drug Development

   • Torbjörn Callréus

   Correspondence 20 November 2012 Pages: 529 - 530

9. The Authors’ Reply

   • John-Joseph Borg
   • George Aislaitner
   • Stephen Mifsud

   Correspondence 20 November 2012 Pages: 530 - 531